SYNGLUTRA 5/1000


Extended release tablets
scheduling status
S4
registration number
53/21.2/0651
What SYNGLUTRA 5/1000 contains
Dapagliflozin (as dapagliflozin propanediol) and Metformin hydrochloride.
other ingredients
Carboxymethylcellulose sodium, Copovidone, Crospovidone, Ferric oxide red (E172), Hypromellose, Magnesium stearate, Mannitol, Microcrystalline cellulose, Silicon dioxide, Opadry II 85F565267 Brown film coating (Iron oxide red (E172), Iron oxide yellow (E172), Macrogol (E1521), Part hydrolysed polyvinyl alcohol (E1203), Talc (E553b),Titanium dioxide (E171).
Therapeutic classification
A10BD15.
© 2026 SAHPRA. ALL RIGHTS RESERVED